CCM
NRXPW

CAAS Capital Management’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

CAAS Capital Management’s Portfolio NRXPW Stock Details NRXPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-66,747
Closed -$649K – 1200
2021
Q1 		$649K Buy
+66,747
New +$543K 0.01% 872

Other funds holding NRXPW

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

CAAS Capital Management's NRXPW Position: Q2 2021 in Review

CAAS Capital Management sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q2 2021, closing a stake of 66,747 shares — an estimated $649K sold.

CAAS Capital Management first reported a position in NRXPW in Q1 2021 and held it in 1 quarter. The position peaked at $649K in Q1 2021. 4 funds tracked by Wall St. Rank hold NRXPW as of Q2 2021.

  • CAAS Capital Management reported no remaining NRX Pharmaceuticals Warrant position as of Q2 2021 after selling out during the quarter.
  • CAAS Capital Management sold 66,747 NRX Pharmaceuticals Warrant shares in Q2 2021, an estimated $649K.
  • CAAS Capital Management first reported a position in NRX Pharmaceuticals Warrant in Q1 2021 and held it in 1 quarter.
  • CAAS Capital Management's NRX Pharmaceuticals Warrant position peaked at $649K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q2 2021.

Based on CAAS Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.